jueves, 18 de septiembre de 2025

Editorial p801 NINDS at the forefront of epilepsy research for 75 years The Lancet Neurology + +...

Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00269-8/abstract?dgcid=raven_jbs_etoc_feature_laneur Editorial p801 NINDS at the forefront of epilepsy research for 75 years The Lancet Neurology https://www.thelancet.com/journals/laneur/issue/vol24no10/PIIS1474-4422(25)X0010-7

No hay comentarios:

Publicar un comentario